Pomegranate juice could help prevent prostate cancer recurrence, finds a new study.
During the study, the researchers followed a total of 48 participants over six years. These patients were asked to drinking eight ounces of pomegranate juice daily.
The participants had a rising PSA after surgery or radiotherapy, a PSA greater than 0.2 ng/ml and less than five ng/ml and a Gleason score of seven or less.
The men who remained in the study experienced a significant increase in PSA doubling time following treatment, from a mean of 15.4 months to 60 months, researchers said.
"This study suggests that pomegranate juice may effectively slow the progression of prostate cancer after unsuccessful treatment," said Dr Christopher Amling, an AUA spokesman.
"This finding and other ongoing research might one day reveal that pomegranate juice is an effective prostate cancer preventative agent as well."
The study results were presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA).